PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21310938-7	2011	We report the efficacy of tacrolimus (FK506) in increasing ENG and ALK1 expression.	Tacrolimus	26-36	activin A receptor like type 1	Homo sapiens	67-71	
21310938-7	2011	We report the efficacy of tacrolimus (FK506) in increasing ENG and ALK1 expression.	Tacrolimus	38-43	activin A receptor like type 1	Homo sapiens	67-71	
21310938-11	2011	Here, we find that the immunosuppressor FK506 increases the protein and mRNA expression of ENG and ALK1 in cultured endothelial cells and enhances the TGF-beta1/ALK1 signaling pathway and endothelial cell functions like tubulogenesis and migration.	Tacrolimus	40-45	activin A receptor like type 1	Homo sapiens	99-103	
21310938-11	2011	Here, we find that the immunosuppressor FK506 increases the protein and mRNA expression of ENG and ALK1 in cultured endothelial cells and enhances the TGF-beta1/ALK1 signaling pathway and endothelial cell functions like tubulogenesis and migration.	Tacrolimus	40-45	activin A receptor like type 1	Homo sapiens	161-165	
30260738-5	2019	Recently, it was shown that tacrolimus increased ALK-1 signaling and had beneficial effects in selected end-stage PAH patients.	Tacrolimus	28-38	activin A receptor like type 1	Homo sapiens	49-54